Literature DB >> 64320

Effects of cycle length on atrial vulnerability.

C R Wyndham, F Amat-y-Leon, D Wu, P Denes, R Dhingra, R Simpson, K M Rosen.   

Abstract

The effect of cycle length on atrial vulnerability was studied in 14 patients manifesting reproducible repetitive atrial firing during atrial extra-stimulus (A2) testing. Repetitive atrial firing was defined as the occurrence of two or more premature atrial responses with return cycle (A2-A3) of 250 msec or less and subsequent mean cycle length of 300 msec or less, following A2. The zone of repetitive atrial firing could be defined in terms of its longest and shortest A1-A2 coupling intervals. Each patient was tested at a long cycle length (CL1) (mean 884 msec) and a short cycle length (CL2) (mean 557 msec). CL1 was sinus rhythm and CL2, an atrial paced rhythm. Repetitive atrial firing occurred in two patients at CL1 and in all patients at CL2. Of the former two patients (group 2), the zone of repetitive atrial firing was markedly widened in one at CL2 due to a shortening of atrial functional refractory period (FRP) at CL2. In the other, zone of repetitive atrial firing could not be totally defined due to induction of sustained atrial flutter preventing definition of atrial FRP. The occurrence of repetitive atrial firing at only CL2 in 12 patients (group 1) reflected: 1) a shortening of atrial FRP from 294 +/- 11 msec at CL1 to 242 +/- 10 msec at CL2 (mean +/- SEM; P less than 0.01), allowing delivery of A2 at shorter coupling intervals (9); 2) the new occurrence of repetitive atrial firing at A1-A2 coupling intervals achievable at both cycle lengths (1); or 3) both effects (2). In conclusion, decrease of cycle length potentiated atrial vulnerability. This demonstration implies that atrial pacing could potentiate occurrence of paroxysmal atrial fibrillation or flutter.

Entities:  

Mesh:

Year:  1977        PMID: 64320     DOI: 10.1161/01.cir.55.2.260

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  9 in total

1.  Electrophysiological Changes of the Atrium in Patients with Lone Paroxysmal Atrial Fibrillation.

Authors:  Osmar Antonio Centurion; Shojiro Isomoto; Akihiko Shimizu
Journal:  J Atr Fibrillation       Date:  2010-06-01

2.  Development of malignant ventricular arrhythmias in a young male with WPW pattern.

Authors:  Alim Erdem; Nihat Madak; Ahmet Yilmaz; Osman Can Yontar; Hasan Yucel; Ibrahim Gul; Izzet Tandogan
Journal:  Indian Pacing Electrophysiol J       Date:  2010-04-01

3.  Effect of intravenous flecainide on atrial vulnerability in man.

Authors:  T Pop; N Treese; J C Kang; T Meinertz; W Kasper
Journal:  Klin Wochenschr       Date:  1983-06-15

4.  Evaluation of atrial vulnerability immediately after radiofrequency catheter ablation of accessory pathway in patients with Wolff-Parkinson-White syndrome.

Authors:  Kumral Ergun Cagli; Serkan Topaloglu; Dursun Aras; Nihat Sen; Ibrahim Akpinar; Akif Durak; Halil Lutfi Kisacik
Journal:  J Interv Card Electrophysiol       Date:  2009-10-21       Impact factor: 1.900

5.  The vulnerability of the right atrium. III. Electrophysiologic correlates of atrial vulnerability.

Authors:  T Pop; D Fleischmann; S Effert
Journal:  Klin Wochenschr       Date:  1979-01-01

6.  Effect of intravenous flecainide on atrial vulnerability in man.

Authors:  T Pop; N Treese
Journal:  Drugs       Date:  1985       Impact factor: 9.546

7.  Ventricular fibrillation development following atrial fibrillation after the ingestion of sildenaphil in a patient with Wolff-Parkinson-White syndrome.

Authors:  Sinan Inci; Ibrahim Izgu; Halil Aktas; Pinar Dogan; Ali Dogan
Journal:  Intractable Rare Dis Res       Date:  2015-08

8.  Severe aortic stenosis in elderly patients.

Authors:  E Nylander; I Ekman; T Marklund; B Sinnerstad; E Karlsson; B Wranne
Journal:  Br Heart J       Date:  1986-05

9.  Atrioventricular Node Slow-Pathway Ablation Reduces Atrial Fibrillation Inducibility: A Neuronal Mechanism.

Authors:  Xiaomeng Yin; Yutao Xi; Shulong Zhang; Yunlong Xia; Lianjun Gao; Jinqiu Liu; Nancy Cheng; Qi Chen; Jie Cheng; Yanzong Yang
Journal:  J Am Heart Assoc       Date:  2016-06-10       Impact factor: 5.501

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.